| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/29/1993 | EP0247091B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 09/29/1993 | EP0245459B1 T-cell lymphotrophic virus protein and assay |
| 09/29/1993 | CN1076729A Enkephalin-interferon fusion protein for tumour and its preparation method |
| 09/28/1993 | US5248607 Monoclonal antibodies and hybridomas specific for green-oat phytochrome |
| 09/28/1993 | US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
| 09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
| 09/24/1993 | WO1993019185A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 09/24/1993 | CA2132420A1 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine |
| 09/23/1993 | DE4209216A1 Humaner t-zell-marker ht6 Human t-cell marker HT6 |
| 09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |
| 09/22/1993 | EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors |
| 09/22/1993 | EP0561429A1 Method of preparing crystalline GM-CSF |
| 09/22/1993 | EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides |
| 09/22/1993 | EP0561297A2 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/22/1993 | EP0561194A2 Anti-feline calicivirus recombinant antibody and gene fragment encoding the same |
| 09/22/1993 | EP0561183A1 Anti-ganglioside monoclonal antibody, its preparation and use as a tumour therapeutic agent |
| 09/22/1993 | EP0561137A1 Hybrid DNA Synthesis of Mature Insulin-like Growth Factors |
| 09/22/1993 | EP0561087A1 Mutated form of the beta-amyloid precursor protein gene |
| 09/22/1993 | EP0560969A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/22/1993 | EP0560924A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 09/22/1993 | EP0560913A1 Bifunctional inhibitors of thrombin and platelet activation |
| 09/22/1993 | EP0560890A1 A novel protein tyrosine kinase |
| 09/21/1993 | US5247070 N-terminal muteins of tumor necrosis factor |
| 09/21/1993 | US5246851 Neisseria diagnosis and binding |
| 09/21/1993 | US5246844 Detection of Lyme disease |
| 09/21/1993 | US5246831 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 09/21/1993 | US5246718 Enzymatic peptidolysis |
| 09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
| 09/20/1993 | CA2091971A1 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/19/1993 | CA2090303A1 Process for the expression of herpes simplex virus type 1 glycoprotein 1 and methods of use |
| 09/16/1993 | WO1993018185A1 Receptor internalization signals |
| 09/16/1993 | WO1993018180A1 Method for enzymatically synthesizing peptide alkyl esters, resulting products and use thereof |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018152A1 Mn gene and protein |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018146A2 Proteins forming complexes with chaperones and ligands thereof, fragments thereof, preparation thereof and biological uses thereof |
| 09/16/1993 | WO1993018145A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR) |
| 09/16/1993 | WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | WO1993018141A1 Thrombin receptor antagonists |
| 09/16/1993 | WO1993018134A1 Strain w micro-organism, enzyme compositions obtainable therefrom, use of the micro-organism and hydrolysis process especially of keratin |
| 09/16/1993 | WO1993018066A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | WO1993018047A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 09/16/1993 | WO1993017970A1 Enzymatic processing of materials containing chromium and protein |
| 09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017705A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017694A1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease |
| 09/16/1993 | DE4208275A1 Mikroorganismus stamm w Microorganism-derived w |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | CA2131909A1 Selectively deglycosylated human immunodeficiency virus type i envelope vaccines |
| 09/16/1993 | CA2131692A1 An anti-idiotypic antibody and its use in diagnosis and therapy in hiv-related disease |
| 09/16/1993 | CA2131637A1 Process for enzyme synthesis of alkyl esters of peptides, products thus obtained and use of the said products |
| 09/16/1993 | CA2131552A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | CA2131444A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | CA2130359A1 Compositions and methods for modulating rna |
| 09/16/1993 | CA2130100A1 Receptor internalization signals |
| 09/16/1993 | CA2126970A1 Insectidal toxins from the parasitic wasp bracon hebetor |
| 09/15/1993 | EP0560401A1 Site Selective Genomic Modification of Yeast of the Genus Pichia |
| 09/15/1993 | EP0559871A1 Method for the determination of sulfidoleukotrienes in tissues and biological fluids and its application in diagnosis of allergies and other inflammatory diseases. |
| 09/15/1993 | EP0559834A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 09/15/1993 | EP0559770A1 Cell stress transcriptional factors |
| 09/15/1993 | EP0559769A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 09/15/1993 | EP0559725A1 Structural proteins from artificial genes |
| 09/15/1993 | CN1022113C Protein and its production method |
| 09/14/1993 | US5245010 Polypeptide of herpes simplex virus vmw 65 protein |
| 09/14/1993 | US5244801 Process for producing monoclonal antibodies which specifically bind to benign colonic adenomatous polyps of human origin and hybridomas and monoclonal antibodies produced by said process |
| 09/14/1993 | US5244793 TGF-β1/β2: a novel chimeric transforming growth factor-beta |
| 09/14/1993 | US5244656 Antigen specific plasmacytomas and antibodies derived therefrom |
| 09/14/1993 | CA2092645A1 Production of recombinant proteins using herpes virus promoters and vp16 transactivators |
| 09/14/1993 | CA1322157C Bifunctional proteins |
| 09/08/1993 | EP0559632A2 Method of producing tissue factor pathway inhibitor |
| 09/08/1993 | EP0559428A2 Novel polypeptides and DNAs encoding them |
| 09/08/1993 | EP0559249A1 Determination method |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0559175A2 gamma-Polyglutamate hydrolase and process for producing same |
| 09/08/1993 | EP0558491A1 Virus resistance in plants |
| 09/08/1993 | EP0505353B1 Fast printer with a particle trap in the paper channel |
| 09/08/1993 | EP0307434B1 Altered antibodies |
| 09/08/1993 | CN1075983A Direct demonstration of human insulin precursor-gene in bacillus coli and after-processing method |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242813 Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| 09/07/1993 | US5242810 Bifunctional inhibitors of thrombin and platelet activation |
| 09/07/1993 | CA1321963C Modification of the dna sequence between the shine-dalgarno sequence and the start codon of the trp operon to increase protein expression |
| 09/06/1993 | CA2090957A1 Anti-tumor method and anti-tumor agent |
| 09/05/1993 | WO1993017697A1 Method of delivering therapeutic substances to the brain |
| 09/05/1993 | CA2102519A1 Method of delivering therapeutic substances to the brain |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017341A1 Htlv-i/htlv-ii assay and method |
| 09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
| 09/02/1993 | WO1993017111A1 Hepatitis c virus peptides |
| 09/02/1993 | WO1993017107A1 Improvements in or relating to malaria vaccine |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017105A1 Altered antibodies, products and processes relating thereto |
| 09/02/1993 | WO1993017101A1 Endo-1,4-beta-d-glucanase |